AAAAAA

   
Results: 1-21 |
Results: 21
Lymphoma rate rise continues to baffle researchers
Authors: Garber, K
Citation: K. Garber, Lymphoma rate rise continues to baffle researchers, J NAT CANC, 93(7), 2001, pp. 494-496
Beyond the nobel prize: Cell cycle research offers new view of cancer
Authors: Garber, K
Citation: K. Garber, Beyond the nobel prize: Cell cycle research offers new view of cancer, J NAT CANC, 93(23), 2001, pp. 1766-1768
Rapamycin's resurrection: A new way to target the cancer cell cycle
Authors: Garber, K
Citation: K. Garber, Rapamycin's resurrection: A new way to target the cancer cell cycle, J NAT CANC, 93(20), 2001, pp. 1517-1519
Rapamycin may prevent post-transplant lymphoma
Authors: Garber, K
Citation: K. Garber, Rapamycin may prevent post-transplant lymphoma, J NAT CANC, 93(20), 2001, pp. 1519-1519
STI571 revolution: Can the newer targeted drugs measure up?
Authors: Garber, K
Citation: K. Garber, STI571 revolution: Can the newer targeted drugs measure up?, J NAT CANC, 93(13), 2001, pp. 970-973
Van Andel Institute brings cancer research to the heartland
Authors: Garber, K
Citation: K. Garber, Van Andel Institute brings cancer research to the heartland, J NAT CANC, 93(11), 2001, pp. 803-804
Biotech industry faces new bottleneck
Authors: Garber, K
Citation: K. Garber, Biotech industry faces new bottleneck, NAT BIOTECH, 19(3), 2001, pp. 184-185
Tumor tracker
Authors: Garber, K
Citation: K. Garber, Tumor tracker, TECHNOL REV, 104(3), 2001, pp. 31-31
An end to Alzheimer's?
Authors: Garber, K
Citation: K. Garber, An end to Alzheimer's?, TECHNOL REV, 104(2), 2001, pp. 70
New discoveries still abundant in monoclonal antibody research
Authors: Garber, K
Citation: K. Garber, New discoveries still abundant in monoclonal antibody research, J NAT CANC, 92(18), 2000, pp. 1462-1464
Tyrosine kinase inhibitor research presses on despite halted clinical trial
Authors: Garber, K
Citation: K. Garber, Tyrosine kinase inhibitor research presses on despite halted clinical trial, J NAT CANC, 92(12), 2000, pp. 967-969
Protein C may be sepsis solution
Authors: Garber, K
Citation: K. Garber, Protein C may be sepsis solution, NAT BIOTECH, 18(9), 2000, pp. 917-918
rFactor VIII deficit questioned
Authors: Garber, K
Citation: K. Garber, rFactor VIII deficit questioned, NAT BIOTECH, 18(11), 2000, pp. 1133-1133
Looted culture has no place in an evolving Europe!
Authors: Garber, K
Citation: K. Garber, Looted culture has no place in an evolving Europe!, Z BIBL BIBL, 47(2), 2000, pp. 143-154
The next wave of the genomics business
Authors: Garber, K
Citation: K. Garber, The next wave of the genomics business, TECHNOL REV, 103(4), 2000, pp. 46
High stakes for gene therapy
Authors: Garber, K
Citation: K. Garber, High stakes for gene therapy, TECHNOL REV, 103(2), 2000, pp. 58
Tribal turnabout
Authors: Garber, K
Citation: K. Garber, Tribal turnabout, HOSP HEAL N, 73(4), 1999, pp. 16
Interiors - Doctored design
Authors: Garber, K
Citation: K. Garber, Interiors - Doctored design, HOSP HEAL N, 73(2), 1999, pp. 26-26
Business unusual
Authors: Garber, K
Citation: K. Garber, Business unusual, HOSP HEAL N, 73(2), 1999, pp. 54
The Tpv2 family of retrotransposons of Phaseolus vulgaris: structure, integration characteristics, and use for genotype classification
Authors: Garber, K Bilic, I Pusch, O Tohme, J Bachmair, A Schweizer, D Jantsch, V
Citation: K. Garber et al., The Tpv2 family of retrotransposons of Phaseolus vulgaris: structure, integration characteristics, and use for genotype classification, PLANT MOL B, 39(4), 1999, pp. 797-807
Gene therapy - RAC nixes plan to treat retinoblastoma
Authors: Garber, K
Citation: K. Garber, Gene therapy - RAC nixes plan to treat retinoblastoma, SCIENCE, 284(5423), 1999, pp. 2066-2066
Risultati: 1-21 |